Anteris Technologies Global
AVR | NASDAQ
$5.70
+$0.28 (+5.17%)
At close: Nov 16, 2026, 4:00 PM ET
$5.68
-$0.02 (-0.35%)
After-hours:
Nov 16, 2026, 6:33 PM ET
+5.17%
(1D)No price chart data available for 1D timeframe.
Rating
42
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #469/1021 (Top 46%)
Key Statistics
Market Data
Market Cap $555.71M
1D Range
5.40 5.72
52W Range
3.38 10.57
Valuation (TTM)
PE -2.71
PB 2.45
EV/EBITDA -3.20
Valuation (NTM)
Forward PE N/A
Forward PEG 0.05
Price Target $10.00
Cash Flow
FCF Yield -16.8%
SBC Adj. FCF Yield -18.1%
SBC Impact -7.6%
Margins
Gross Margin 39.3%
Operating Margin -4880.4%
FCF Margin -4002.1%
Growth (CAGR)
Revenue 3Y | 5Y -2.0% |
-18.9%
Dil EPS 3Y | 5Y -2.5% |
-39.5%
FCF 3Y | 5Y -26.6% |
-35.8%
Returns
ROA -41.2%
ROE -57.2%
ROIC -46.6%
Financial Health
Net Cash
$232.58M
Current Ratio 12.45
Interest Coverage -2,107.59
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with ao...
Sector Healthcare
Industry Medical - Devices
Employees 174
IPO Date Dec 13, 2024
Website anteristech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.28
Beat +10.08%
YoY:
+54.84% REV
$519K
Miss -81.13%
YoY:
+20.98%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$10.00
Upside
+75.44%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AVR